|
|
Volumn 11, Issue 4, 2015, Pages 807-
|
|
Letter from the editor
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA VACCINE;
GI 4000 VACCINE;
GX301 VACCINE;
HEPATITIS E VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INFLUENZA VACCINE;
LEPTOSPIROSIS VACCINE;
MENINGOCOCCUS VACCINE;
PNEUMOCOCCUS VACCINE;
RECOMBINANT HEPATITIS HIB CONJUGATE VACCINE;
UNCLASSIFIED DRUG;
VACCINE;
VARICELLA ZOSTER VACCINE;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOTHERAPY;
INFLUENZA;
LEPTOSPIROSIS;
LETTER;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 4 CLINICAL TRIAL (TOPIC);
RESPIRATORY TRACT INFLAMMATION;
RHEUMATOID ARTHRITIS;
VACCINATION;
NEOPLASM;
PROCEDURES;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
VACCINATION;
|
|
EID: 84945200107
PISSN: 21645515
EISSN: 2164554X
Source Type: Journal
DOI: 10.1080/21645515.2015.1034509 Document Type: Letter |
|
Times cited : (1)
|
|
References (0)
|